Rationale and evidence for the use of oxcarbazepine in neuropathic pain

Journal of Pain and Symptom Management

Volumn 25, Issue 5 SUPPL., 2003, Pages

  Carrazana, Enrique ^a   Mikoshiba, Imao ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Antiepileptic drug; Neuropathic pain; Oxcarbazepine; Painful diabetic neuropathy; Refractory pain; Trigeminal neuralgia

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; OXCARBAZEPINE;

ANALGESIA; ARTICLE; ATAXIA; CLINICAL TRIAL; CONSTIPATION; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; FATIGUE; HEADACHE; HUMAN; HYPONATREMIA; META ANALYSIS; NAUSEA; NEUROPATHIC PAIN; SEDATION; SIDE EFFECT; TRIGEMINUS NEURALGIA; VERTIGO; VISUAL IMPAIRMENT;

EID: 0037403147     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(03)00067-8     Document Type: Article

References (25)

1. Bergouignan M. Cures heureuses de nevralgies faciales essentielles par le diphenylhydantoinate de soude. Rev Laryngol Otol Rhinol. 63:1942;34-41.
2. Blom S. Trigeminal neuralgia. its treatment with a new anticonvulsant drug (G32883) Lancet. 1:1962;839-840.
3. Campbell F.G., Graham J.G., Zilkha K.J. Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiat. 29:1966;265-267.
4. Killian J.M., Fromm G.H. Carbamazepine in the treatment of neuralgia. use and side effects Arch Neurol. 19:1968;129-136.
5. Nicol C.F. A four year double-blind study of tegretol in facial pain. Headache. 9:1969;54-57.
6. Jensen T.S. Anticonvulsants in neuropathic pain. rationale and clinical evidence Eur J Pain. 6(Suppl A):2002;61-68.
7. Dickenson A.H., Matthews E.A., Suzuki R. Neurobiology of neuropathic pain. mode of action of anticonvulsants Eur J Pain. 6(Suppl A):2002;51-60.
8. White H.S. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia. 40(Suppl 5):1999;S2-S10.
9. Ichikawa K., Koyama N., Kiguchi S.et al. Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers. Eur J Pharmacol. 420:2001;119-122.
10. McLean M.J., Schmutz M., Wamil A.W.et al. Oxcarbazepine. mechanisms of action Epilepsia. 35(Suppl 3):1994;S5-S9.
11. Stefani A., Pisani A., De Murtas M.et al. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents. Epilepsia. 36:1995;997-1002.
12. Dam M., Ekberg R., Loyning Y.et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res. 3:1989;70-76.
13. Bill P.A., Vigonius U., Pohlmann H.et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res. 27:1997;195-204.
14. Guerreiro M.M., Vigonius U., Pohlmann H.et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 27:1997;205-213.
15. Beydoun A., Kutluay E. Oxcarbazepine. Expert Opin Pharmacother. 3:2002;59-71.
16. Lloyd P., Flesch G., Dieterle W. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia. 35(Suppl 3):1994;S10-S13.
17. Zakrzewska J.M., Patsalos P.N. Oxcarbazepine. a new drug in the management of intractable trigeminal neuralgia J Neurol Neurosurg Psychiatry. 52:1989;472-476.
18. Farago F. Trigeminal neuralgia. its treatment with two new carbamazepine analogues Eur Neurol. 26:1987;73-83.
19. Lindstrom P. The analgesic effect of carbamazepine in trigeminal neuralgia. Pain. 4:1987;S85.
20. Beydoun A, Schmidt D, D'Souza J, on behalf of the Oxcarbazepine Study Group. Meta-analysis of comparative trials of oxcarbazepine versus carbamazepine in trigeminal neuralgia. Poster presented at the 21st American Pain Society Annual Meeting, Baltimore, USA, 14-17 March 2002.
21. Royal M, Bhakta B, Jensen M, et al. An open-label trial of oxcarbazepine in patients with complex regional pain syndrome refractory to gabapentin. Poster presented at the 17th American Academy of Pain Medicine Annual Meeting, Florida, USA, 14-18 February 2001.
22. Ward S., Royal M.A., Jenson M. An open-label trial of oxcarbazepine in patients with radiculopathy refractory to gabapentin. J Pain. 3:2002;42.
23. Jenkins K., Kaplan S.E., Leahy L.F.et al. Oxcarbazepine in central neuropathic pain with allodynia following spinal cord injury. J Pain. 3:2002;10.
24. Rull J.A., Quibrera R., Gonzalez-Milan H.et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol). double blind crossover trial Diabetologia. 5:1969;215-220.
25. Carrazana E, Beydoun A, Kobetz S, et al. An open-label, prospective trial of oxcarbazepine for the treatment of painful diabetic neuropathy. Poster presented at the 21st American Pain Society Annual Meeting, Baltimore, USA, 14-17 March 2002.